Northwestern Mutual Wealth Management CO Avidity Biosciences, Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $112 Billion
- Q3 2024
A detailed history of Northwestern Mutual Wealth Management CO transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 40 shares of RNA stock, worth $1,186. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40Holding current value
$1,186% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding RNA
# of Institutions
252Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$316 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$274 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$256 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$241 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$209 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.55B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...